Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax COIN Option Income Strategy ETF (CONY) vs Tempus AI (TEM) Price & Performance

YieldMax COIN Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

YieldMax COIN Option Income Strategy ETF vs Tempus AI — how do they compare? YieldMax COIN Option Income Strategy ETF trades at $18.62 (market cap $384.59M), while Tempus AI trades at $70.03 (market cap $12.77B). The key difference: Tempus AI is far larger — about 33.2× YieldMax COIN Option Income Strategy ETF's market cap, and Tempus AI is trading nearer its 52-week high, YieldMax COIN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax COIN Option Income Strategy ETF for 41 Days and Tempus AI for 22 Days on average.

CONYTEM
Market Cap
$384.59M$12.77B
Volume
792,6538,980,490
Sector
Income / Options OverlayBroad Market / Factor
52-Week High
$76.50$99.28
52-Week Low
$17.73$41.55
Typical Hold Time
41 Days22 Days
Enterprise Value
—$13.40B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax COIN Option Income Strategy ETF

CONY trades at $19.16, down 3.38% today, with a bearish technical outlook as moving averages signal selling pressure. The ETF maintains weekly dividend distributions but faces structural NAV erosion concerns. Recent news highlights regulatory uncertainty impacting crypto-related stocks after Senate cryptocurrency legislation failed to advance.

The outlook remains challenging with significant YTD price decline and ongoing NAV decay despite high distribution rates. Investment opportunity exists for income-focused investors seeking weekly dividends, but structural risks and crypto market volatility present substantial downside exposure.

Tempus AI

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.

Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CONY
98% Buy2% Sell
Avg holding period · 41 Days
TEM
24% Buy76% Sell
Avg holding period · 22 Days

About YieldMax COIN Option Income Strategy ETF

CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.

Read more on CONY →

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM →